How should I dose nortriptyline oral solution (10 mg per 5 mL) to provide a dose equivalent to a 25‑mg tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nortriptyline Oral Solution Dosing for 25 mg Equivalent

To deliver a 25 mg dose using nortriptyline 10 mg/5 mL oral solution, administer 12.5 mL of the solution.

Calculation and Rationale

The FDA-approved nortriptyline oral solution is supplied as 10 mg per 5 mL 1. Using basic proportional calculation:

  • Desired dose: 25 mg
  • Available concentration: 10 mg/5 mL (or 2 mg/mL)
  • Volume required: (25 mg ÷ 10 mg) × 5 mL = 12.5 mL

Administration Guidelines

Measurement and delivery:

  • Use a calibrated oral syringe or dosing cup to ensure accurate measurement of 12.5 mL 1
  • Do not use household spoons, as they provide inconsistent volumes and may lead to dosing errors 1

Storage and handling:

  • Store at 20°–25°C (68°–77°F) with excursions permitted between 15°–30°C (59°–86°F) 1
  • Protect from light and keep the container tightly closed 1

Clinical Context for Nortriptyline Dosing

Typical adult dosing:

  • Initial doses typically start at 25 mg before bed, then titrate to 75 mg/day or the maximal tolerated dose 2
  • Some protocols use 75–125 mg initial doses depending on weight in inpatient settings, with therapeutic drug levels often reached within the first week 3
  • Target therapeutic plasma levels are generally 50–139 ng/mL, as levels above 200 ng/mL are associated with significantly poorer clinical responses 4, 5

Common pitfalls to avoid:

  • Nortriptyline causes frequent adverse effects including dry mouth (64%) and dysgeusia (20%) 2
  • Orthostatic hypotension is the cardiovascular side effect of major concern, though it occurs in a minority of patients 3
  • Approximately one-third of patients may be unable to complete trials due to tolerability issues 6

References

Research

A randomized trial of nortriptyline for smoking cessation.

Archives of internal medicine, 1998

Research

High initial nortriptyline doses in the treatment of depression.

The Journal of clinical psychiatry, 1993

Research

High plasma nortriptyline levels in the treatment of depression. I.

Clinical pharmacology and therapeutics, 1978

Research

Nortriptyline plasma levels and therapeutic response.

Clinical pharmacology and therapeutics, 1976

Research

Nortriptyline for treatment-resistant depression.

The Journal of clinical psychiatry, 2003

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.